These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 7723338

  • 1. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI.
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [Abstract] [Full Text] [Related]

  • 2. Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
    van den Broek SA, de Graeff PA, van Veldhuisen DJ, van Gilst WH, Hillege H, Wesseling H, Lie KI.
    J Card Fail; 1997 Sep; 3(3):165-71. PubMed ID: 9330124
    [Abstract] [Full Text] [Related]

  • 3. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD, Fisher MB, Rush JE.
    Am J Med; 1988 Sep 23; 85(3B):44-7. PubMed ID: 2844087
    [Abstract] [Full Text] [Related]

  • 4. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA.
    J Hypertens; 1992 Aug 23; 10(8):803-12. PubMed ID: 1325513
    [Abstract] [Full Text] [Related]

  • 5. Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.
    Bellissant E, Annane D, Pussard E, Thuillez C, Giudicelli JF.
    Fundam Clin Pharmacol; 1996 Aug 23; 10(2):127-35. PubMed ID: 8737955
    [Abstract] [Full Text] [Related]

  • 6. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J, Pinto YM, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H.
    Cardiovasc Res; 1991 Nov 23; 25(11):936-42. PubMed ID: 1813122
    [Abstract] [Full Text] [Related]

  • 7. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ, Lees KR, Reid JL.
    Br Heart J; 1991 Sep 23; 66(3):206-11. PubMed ID: 1657084
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT, Talsness CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ.
    Circulation; 1992 Nov 23; 86(5):1566-74. PubMed ID: 1330361
    [Abstract] [Full Text] [Related]

  • 9. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb 23; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 10. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure.
    Widimský J, Kremer HJ, Jerie P, Uhlír O.
    Eur J Clin Pharmacol; 1995 Feb 23; 49(1-2):95-102. PubMed ID: 8751029
    [Abstract] [Full Text] [Related]

  • 11. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD, Katz R, Sullivan JM, Wolfson P, Haugland M, Kirlin P, Powers E, Rich S, Hackshaw B, Chiaramida A.
    J Am Coll Cardiol; 1989 May 23; 13(6):1240-7. PubMed ID: 2539403
    [Abstract] [Full Text] [Related]

  • 12. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L, Stewart M, Padfield P, Channer K.
    J Cardiovasc Pharmacol; 1998 Dec 23; 32(6):988-94. PubMed ID: 9869506
    [Abstract] [Full Text] [Related]

  • 13. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A, Boner G, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 23; 1(4):365-8. PubMed ID: 11967825
    [Abstract] [Full Text] [Related]

  • 14. The acute hemodynamic, hormonal, and pharmacokinetic properties of oral spirapril in patients with moderate to severe heart failure.
    van den Broek SA, van Bruggen A, de Graeff PA, Hillege H, van Gilst WH, Wesseling H, Lie KI.
    J Cardiovasc Pharmacol; 1991 Oct 23; 18(4):614-21. PubMed ID: 1724540
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of spirapril in mild-to-moderate hypertension.
    Hayduk K, Kraul H.
    J Cardiovasc Pharmacol; 1999 Aug 23; 34 Suppl 1():S19-23. PubMed ID: 10499560
    [Abstract] [Full Text] [Related]

  • 16. First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators.
    Lang RM, DiBianco R, Broderick GT, Gottlieb SS, Kostis J, Lyle PA, Makris L, Rajfer SI, Rucinska EJ.
    Am Heart J; 1994 Sep 23; 128(3):551-6. PubMed ID: 8074019
    [Abstract] [Full Text] [Related]

  • 17. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements.
    Veerman DP, Douma CE, Jacobs MC, Thien T, Van Montfrans GA.
    Br J Clin Pharmacol; 1996 Jan 23; 41(1):49-56. PubMed ID: 8824693
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic-pharmacodynamic model relating spiraprilat plasma concentrations to systemic and regional hemodynamic effects in congestive heart failure.
    Bellissant E, Chau NP, Thuillez C, Gerbeau C, Richard C, Giudicelli JF.
    J Cardiovasc Pharmacol; 1997 Aug 23; 30(2):253-60. PubMed ID: 9269955
    [Abstract] [Full Text] [Related]

  • 19. Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure.
    Haffner CA, Kendall MJ, Struthers AD, Bridges A, Stott DJ.
    Postgrad Med J; 1995 May 23; 71(835):287-92. PubMed ID: 7596934
    [Abstract] [Full Text] [Related]

  • 20. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
    Shohat J, Wittenberg C, Erman A, Rosenfeld J, Boner G.
    Scand J Urol Nephrol; 1999 Feb 23; 33(1):57-62. PubMed ID: 10100366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.